VERBESSERTE PEPTIDARZNEIMITTEL

European patent · EP2922877 · In force

Register entry

Publication number
EP2922877
Application number
EP13857269
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Nov 20, 2013
Published
Sep 30, 2015
Granted
Sep 5, 2018
Protection ends at the latest
Nov 19, 2033
Next annual fee due
Nov 30, 2026
IPC classes
C07K 19/00 (2006.01)
C07K 7/06 (2006.01)
A61K 38/08 (2006.01)
C07K 1/107 (2006.01)
A61K 38/00 (2006.01)
C07K 5/065 (2006.01)
A61K 38/07 (2006.01)
A61K 38/26 (2006.01)
A61K 38/29 (2006.01)
C09D 101/28 (2006.01)
Priority
US 201261728667 P 20.11.2012
PCT application
PCT/US2013/071067 20.11.2013
PCT publication
WO2014/081864 30.05.2014
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Dec 1, 2025

    Change

    Published in Swissreg on 01.12.2025

  2. Dec 1, 2024

    Change

    Published in Swissreg on 01.12.2024

  3. Dec 1, 2023

    Change

    Published in Swissreg on 01.12.2023

  4. Dec 6, 2022

    Change

    Published in Swissreg on 06.12.2022

  5. Nov 30, 2018

    Address changed

    Owner
    Eumederis Pharmaceuticals, Inc., 12707 High Bluff Drive, Suite 200, San Diego, CA 92130, USA → Eumederis Pharmaceuticals, Inc., 7515 Guinevere Drive, Sugar Land, Texas 77479, USA

    Published in Swissreg on 30.11.2018

  6. Sep 5, 2018

    Granted

    Published in Swissreg on 05.09.2018

Parties

Holder

Eumederis Pharmaceuticals, Inc.

7515 Guinevere Drive, Sugar Land, Texas 77479, US

Inventor

NESTOR, John, J.

Encinitas, CA 92024, US

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.